COVID-19: Melatonin as a potential adjuvant treatment - Zhang, Rui; Wang, Xuebin; Ni, Leng; Di, Xiao; Ma, Baitao; Niu, Shuai; Liu, Changwei; Reiter, Russel J. (Life sciences (1973), 2020)
Keywords: Acute Lung Injury - virology; acute respiratory distress syndrome; Adjuvant therapy; adjuvants; Adjuvants, Immunologic - therapeutic use; Anti-Inflammatory Agents - therapeutic use; Antioxidants - therapeutic use; anxiety; Attenuation; Betacoronavirus; clinical trials; Coronavirus infections; Coronavirus Infections - drug therapy; Coronavirus Infections - immunology; Coronaviruses; COVID-19; COVID-19 Drug Treatment; Cytokine storm; Cytokines; Cytokines - immunology; death; distress; Humans; Immune response; Immunomodulation; Inflammation; Inflammation - drug therapy; lungs; Melatonin; Melatonin - therapeutic use; Orthocoronavirinae; Oxidation; Oxidation-reduction; pandemic; Pandemics; Pathogenesis; Pathogens; Pathology; Patients; Permeability; Pneumonia, Viral - drug therapy; Pneumonia, Viral - immunology; Respiratory diseases; Respiratory distress syndrome; Respiratory Distress Syndrome - virology; SARS-CoV-2; sedation; Viral diseases; Viruses; COVID-19; SARS-CoV-2; Melatonin; Cytokines; Immunomodulation; Oxidation-reduction